Un moniteur de glucose en continu est un petit capteur porté sur le bras ou l'abdomen. Il échantillonne le liquide sous la peau toutes les quelques minutes et transmet une mesure de glycémie à votre téléphone.
Dans le diabète, c'est l'un des outils les mieux appuyés qui existent, étayé par des essais randomisés. Pour une personne métaboliquement saine, le tableau change : il devient une auto-expérience dont le bénéfice à long terme n'a pas été mesuré.
Findings & Outcomes
What It Is
A coin-sized patch holds a fine filament that sits just under the skin, worn for 10 to 14 days and then replaced. It reads the glucose in the fluid between your cells every one to five minutes and sends the number, with a trend arrow, to a phone or reader.
For someone with diabetes the device replaces roughly 12 fingersticks a day with a continuous picture, and that picture is what the trials are built on. For someone curious about their metabolism it shows how meals, movement, sleep, and stress move a number that used to be invisible between clinic visits.
What It Does
The two uses rest on very different evidence. In diabetes, monitoring lowers HbA1c, raises the time spent in the target range, and cuts dangerous lows. These come from randomized trials at the top of the evidence ladder, and are the basis for its use in type 2 diabetes. In people without diabetes the device has established one finding firmly. In a study of more than 1,000 adults, glucose responses to identical meals varied by around 68 percent from person to person. The drivers were habitual diet, the gut microbiome, sleep, and activity. So a food that raises one person's glucose sharply barely moves another's. That spread is what personalized-nutrition marketing is built on. No trial has shown that a healthy person who eats to the readings ends up healthier. A systematic review of 23 studies in people without diabetes found no appreciable improvement in blood sugar and no change in weight.
The Research & Studies
Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.
Blood Sugar
Diabète de type 1 sous injections : un moniteur a abaissé l'HbA1c d'environ 0.6 % de plus que les piqûres au doigt
Les adultes atteints de diabète de type 1 portant un moniteur au lieu de tester par piqûre au doigt ont abaissé leur marqueur glycémique à long terme (HbA1c) d'environ 0.6 point de pourcentage de plus que les soins habituels, et ont passé moins de temps en hypoglycémie dangereuse.
L'essai randomisé DIAMOND a recruté 158 adultes atteints de diabète de type 1 utilisant des injections d'insuline multiples quotidiennes, avec une HbA1c initiale entre 7.5 % et 9.9 %. Sur 24 semaines, le groupe de surveillance continue du glucose a réduit l'HbA1c de 1.0 % contre 0.4 % pour le groupe témoin, soit une différence ajustée de -0.6 % (IC à 95 % -0.8 % à -0.3 %). Le temps médian sous 70 mg/dL est passé de 80 min/jour (IQR 36-111) chez les témoins à 43 min/jour (IQR 27-69) avec surveillance (P=0.002). Une réduction de 0.6 % de l'HbA1c avec un seul outil de surveillance est importante dans ce domaine.
Le bénéfice ici est bien établi. Dans le diabète de type 1 sous injections, un moniteur est un outil courant, et son usage a sa place dans un plan élaboré avec une équipe diabétologique.
The study · 1
Beck et al., effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial · JAMA 2017;317(4):371-378
Diabète de type 2 sous insuline intensive : l'HbA1c a chuté d'environ 0.3 % de plus avec un moniteur
Les personnes atteintes de diabète de type 2 utilisant beaucoup d'insuline ont abaissé leur HbA1c un peu plus avec un moniteur qu'avec des piqûres au doigt, environ 0.3 point de pourcentage.
Ce volet de DIAMOND a randomisé 158 adultes atteints de diabète de type 2, âgés de 35 à 79 ans (moyenne 60), sous injections d'insuline multiples quotidiennes avec une HbA1c initiale de 7.5 % à 9.9 %. La différence ajustée du changement moyen d'HbA1c favorisait la surveillance à -0.3 % (IC à 95 % -0.5 % à 0.0 %), un effet plus faible que dans le volet type 1, et la plupart des participants ont utilisé le capteur quotidiennement ou presque tout au long des 24 semaines.
Le gain est modeste dans ce groupe ; c'est un élément parmi d'autres pour l'ajustement de l'insuline avec un prescripteur, pas une solution autonome.
The study · 1
Beck et al., continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial · Ann Intern Med 2017;167(6):365-374
Diabète de type 2 sous insuline basale : le temps dans la plage cible est passé à 59 % contre 43 % avec un moniteur
Les personnes atteintes de diabète de type 2 sous insuline de fond une ou deux fois par jour, suivies dans des cabinets de soins primaires ordinaires, ont passé beaucoup plus de temps de la journée dans une plage glycémique saine avec un moniteur, 59 % contre 43 %, et leur HbA1c a encore baissé.
MOBILE a randomisé 175 adultes atteints de diabète de type 2 traités par une ou deux injections quotidiennes d'insuline basale d'action longue ou intermédiaire et sans insuline prandiale, dans des cabinets de soins primaires. Sur huit mois, le groupe de surveillance continue du glucose a atteint 59 % de temps dans la plage 70-180 mg/dL contre 43 % pour les utilisateurs de lecteurs de glycémie, et l'HbA1c est passée de 9.1 % à 8.0 % contre 9.0 % à 8.4 %, soit une différence ajustée de -0.4 % (IC à 95 % -0.8 % à -0.1 % ; P=0.02). Le cadre des soins primaires rapproche ceci de l'usage réel par rapport aux essais en cliniques spécialisées.
Le temps dans la plage cible est le résultat qui change le plus ici ; pour une personne sous insuline basale, il convient d'en discuter avec un clinicien comme objectif aux côtés de l'HbA1c.
The study · 1
Martens et al., effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: the MOBILE randomized clinical trial · JAMA 2021;325(22):2262-2272
The benefit tracks wear: adults using it six or more days a week lowered HbA1c about 0.53%
The monitor helps most when it is actually worn most days. In a trial across ages, adults who wore it six or more days a week improved their HbA1c, while younger people who wore it less did not see the same benefit.
The JDRF continuous glucose monitoring trial randomized 322 adults and children with type 1 diabetes on intensive therapy. Among adults aged 25 and over, HbA1c improved by a mean difference of -0.53% (95% CI -0.71 to -0.35; P<.001), and 83% of that group used the sensor at least six days a week. In younger age groups, where wear was lower, the HbA1c benefit did not reach significance. The effect tracks consistent wear, not occasional use.
Getting value from a monitor means wearing it most days; sporadic use is the common reason it fails to help.
The study · 1
Juvenile Diabetes Research Foundation CGM Study Group (Tamborlane et al.), continuous glucose monitoring and intensive treatment of type 1 diabetes · N Engl J Med 2008;359(14):1464-1476
Diabète de type 2 sans insuline : l'HbA1c a chuté d'environ 1.0 % avec un port intermittent et s'est maintenue pendant un an
Même les personnes atteintes de diabète de type 2 n'utilisant pas d'insuline ont abaissé leur HbA1c un peu plus avec un moniteur porté par intermittence, et l'amélioration a duré environ un an, sans nécessiter de médication supplémentaire.
Vigersky and colleagues randomized 100 adults with type 2 diabetes not on mealtime insulin to intermittent real-time monitoring (four cycles of two weeks on, one week off) or fingerstick self-monitoring. Mean HbA1c reductions in the monitoring group were 1.0%, 1.2%, 0.8% and 0.8% at weeks 12, 24, 38 and 52, versus 0.5%, 0.5%, 0.5% and 0.2% in the fingerstick group (P=.04). The gain held after monitoring stopped and did not require intensified medication, suggesting the improvement came through behavior.
For non-insulin type 2 diabetes, an on-and-off wear pattern, not continuous use, captured the benefit in this trial and keeps cost down.
The study · 1
Vigersky et al., short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes · Diabetes Care 2012;35(1):32-38
The same meal moves people differently: glucose responses varied about 68% across 1,002 adults
Give a large group of people the exact same meal and their blood-sugar responses differ a lot, around 68% between individuals. The same food that barely moves one person can spike another.
The PREDICT study measured postprandial responses to standardized meals in 1,002 twins and unrelated healthy adults in the UK, validated in a US cohort of 100. Between-person variability was large: 103% for blood triglyceride, 68% for glucose and 59% for insulin. For the glucose response, meal macronutrients explained more of the variance (15.4%) than the gut microbiome (6.0%); for the fat response the pattern reversed (microbiome 7.1% versus macronutrients 3.6%). Genetics played a limited role. This is the observation behind personalized-nutrition marketing.
The variation is a reason population averages fit poorly to an individual; it is not, on its own, evidence that eating to your own responses improves health.
The study · 1
Berry et al., human postprandial responses to food and potential for precision nutrition · Nat Med 2020;26(6):964-973
In the severe-glucotype quarter of healthy people, glucose reached prediabetic ranges up to 15% of the time and diabetic 2%, with no disease
Among the roughly one-quarter of healthy people with a severe glucotype, glucose still climbed into a range a chart would call prediabetic up to 15% of the time, and diabetic about 2%, without anything being wrong. Rises after meals are normal physiology.
The glucotypes study put continuous monitors on adults spanning normal to prediabetic glucose regulation and found that glucose dysregulation was more common and varied than standard tests suggest. Among the roughly one-quarter of normoglycemic participants classified as a severe glucotype, glucose reached prediabetic ranges up to 15% of the time and diabetic ranges about 2%. The authors describe distinct patterns (glucotypes) of variability even among people considered normal, which reframes a post-meal rise as expected, not a sign of harm.
Read a single high-looking reading as ordinary physiology, not damage; sustained high glucose, the marker of diabetes, is the pattern that matters.
The study · 1
Hall et al., glucotypes reveal new patterns of glucose dysregulation · PLoS Biol 2018;16(7):e2005143
Prediabetes: a monitor modestly improved blood sugar across 23 studies, an early signal
In people with prediabetes, wearing a monitor was linked to modestly better blood sugar and to sticking with diet and activity changes, an early but promising signal.
Liao and colleagues pooled 23 studies of continuous glucose monitoring in 1,074 non-diabetic participants across 11 countries. Monitoring significantly improved mean blood glucose against controls (P=.03), and use was associated with greater behavioral adherence and specific dietary changes. The review separated the groups: glycemic benefit appeared in people with prediabetes but not in healthy normoglycemic participants, so the effect concentrates where blood sugar is already drifting.
In prediabetes a monitor may reinforce lifestyle change, but it works alongside diet and activity, not in place of them.
The study · 1
Liao et al., continuous glucose monitoring in non-diabetic populations: a systematic review of observational and interventional studies with meta-analysis · Eur J Med Res 2026
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
Metabolically healthy people: no measured blood-sugar or weight benefit from wearing a monitor
In metabolically healthy people, pulling the studies together showed wearing a monitor did not meaningfully improve blood sugar and did not change weight.
The same systematic review of 23 studies in 1,074 non-diabetic people reported that while prediabetic participants saw a glycemic improvement, no appreciable glycemic benefit was observed in healthy normoglycemic populations, and no significant differences in BMI were found between monitoring and control groups. The authors note that standalone weight loss was unlikely without accompanying behavioral interventions, and that evidence on accuracy and glycemic variability in this group remains limited. No trial in this review measured a hard health outcome such as disease incidence or lifespan.
For a metabolically healthy person, treat a monitor as a curiosity or a short self-experiment, not a health intervention, since a measured benefit has not appeared.
The study · 1
Liao et al., continuous glucose monitoring in non-diabetic populations: a systematic review of observational and interventional studies with meta-analysis · Eur J Med Res 2026
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
Behavior Change
Added to a lifestyle program, a monitor lifted goal-setting and attendance in a 13-person pilot
Adding a monitor to a lifestyle program nudged people to track themselves more, set goals and show up more often, an early hint that the feedback can support behavior change.
Bailey and colleagues ran an 8-week randomized pilot in 13 adults with prediabetes or type 2 diabetes (7 control, 6 intervention). The group given real-time continuous monitoring showed significantly greater increases in self-monitoring behavior (P<.01), goal-setting (P=.01) and self-efficacy (P=.01), higher program attendance (P=.03), and were more likely to re-register for further programs (P=.048). Both groups improved waist circumference and fitness. The sample is tiny, so this is a signal to explore, not a settled effect.
As a short-term motivational aid alongside an actual lifestyle plan, a monitor may help engagement; the feedback can support the change, it does not create it.
The study · 1
Bailey et al., self-monitoring using continuous glucose monitors with real-time feedback improves exercise adherence in individuals with impaired blood glucose · Diabetes Technol Ther 2016;18(3):185-193
How It Works
For a person with diabetes the value comes from the pattern over time; a single reading means little. Seeing overnight drift, the meal that pushes glucose highest, and the exercise that lowers it turns an abstract HbA1c into something a person can act on with a clinician. The sensor also flags a low before symptoms arrive. That is why the diabetes trials work: patient and prescriber gain information that was not there before, and treatment adjusts around it.
In a healthy person a rise after eating is normal. Glucose enters the blood, insulin rises, and muscle and liver clear it, returning the level to baseline within about two hours. Among the one-quarter of normoglycemic people with a "severe" glucotype, glucose touches a prediabetic-labeled range up to 15 percent of the time, and a diabetic range about two percent. Nothing is wrong with them.
The readings are accurate; what the evidence does not support is the interpretation that every rise is damage.
Anatomy of the Practice
1What the sensor actually reads
The filament does not touch blood. It sits in interstitial fluid, the watery space around the cells, where glucose arrives from the bloodstream a few minutes after it rises there. An enzyme on the filament reacts with glucose and produces a tiny electrical current the device converts into a reading.
2The lag between fluid and blood
Because glucose has to cross from blood into that fluid, the sensor reads a few minutes behind your actual blood level. In healthy volunteers the delay measured about five to six minutes at rest, and it stretches when glucose is rising or falling fast. A number that is climbing on screen has already climbed a little further in your blood, and a low reading during a rapid fall may lag the real low.
3Where the readings drift
Modern factory-calibrated sensors run an average error near nine percent against laboratory blood, close enough for tracking patterns and far looser than a lab result. Lying on the sensor can produce a false low, called a compression low, that vanishes when you roll off it. The first day of a new sensor is often the least accurate.
The Chinese Medicine View
Chinese medicine reads digestion without any glucose number. Digestion belongs to the Spleen and Stomach: the Stomach receives and ripens the meal, and the Spleen transforms it and distributes what is useful.
Sweet flavor is understood to enter the Spleen and, in small amounts, to support it. A diet heavy in sweet, rich and greasy food is said to overwhelm that transforming function and generate Damp and Phlegm. The signs are heaviness after eating, fatigue, a thick tongue coat and a swollen tongue body. This is a reading of a whole person over time.
The tradition has long held that the same food suits one constitution and burdens another: what nourishes a robust person can generate Damp in someone whose Spleen is weak. The sensor tracks glucose for hours; a practitioner judges the constitution over months, asking how a meal sits, reading the tongue, and taking the pulse.
How To Learn From It
Ways to Do It
This is a medical device. If you have diabetes, its use belongs in a plan with your clinician. If you are healthy and curious, a short defined trial can show you your own patterns without tipping into worry.
The strong results are in diabetes and in people at high risk of dangerous lows. If that is you, this is a conversation with your diabetes team, who can prescribe and interpret it. If you are metabolically healthy, use it out of curiosity.
A single sensor lasts about two weeks, so two to four weeks is enough to see your own patterns before you decide whether to keep going.
The useful questions are the repeatable ones: which meals consistently drive your glucose highest, and how a poor night changes the next morning. One alarming-looking spike after a single meal tells you little, since day-to-day noise and sensor error are large. The value is in what shows up again and again.
The monitor is most useful as feedback on a change you already wanted to make. Refined carbohydrate (the core of ultra-processed food built around sugar, fat, and salt) drives the sharpest rises, so a swap to [whole foods](/go/integrative/practice/whole-foods) is worth watching. So is a [walk after your largest meal](/go/integrative/practice/post-meal-walk), or moving your last meal earlier. Watching the number respond to a deliberate change is more informative than watching it drift.
Cautions
Cautions For This Practice
Extra restraintEverything to be aware of is here, in one place. This practice suits most healthy people; a few situations call for real care.
Type 1 diabetes with unfelt lows: a monitor cut severe low-sugar events from 34 to 14
The IN CONTROL crossover trial studied 52 adults (aged 18 to 75) with type 1 diabetes and impaired awareness of hypoglycemia. During continuous monitoring, time in normoglycemia was 65.0% (95% CI 62.8-67.3) versus 55.4% (53.1-57.7) with self-monitoring, and severe hypoglycemic events fell from 34 to 14 (P=.033). Impaired awareness makes lows dangerous because the usual warning symptoms are absent, and the sensor supplies the warning the body no longer gives.van Beers et al., continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial
The sensor lags real blood sugar about five to six minutes, longer when glucose moves fast
Basu and colleagues used a glucose tracer in eight healthy fasted volunteers to measure the physiological time lag from the intravascular to the interstitial compartment, finding a mean of 5.3 to 6.2 minutes. At rest this delay is small enough not to impair sensor use, but during rapid rises or falls the reading lags the real blood level further. This is why a fast-falling reading can understate an approaching low and a climbing reading has already climbed more in the blood.Basu et al., time lag of glucose from intravascular to interstitial compartment in humans
A tracking tool only
A monitor does not diagnose diabetes or prediabetes, and its readings are not the numbers those diagnoses are made on. Diagnosis rests on a fasting blood sample, an HbA1c or a glucose tolerance test done in a laboratory. If the trend on a sensor worries you, ask a clinician for a proper blood test before acting on the reading.
Do not treat a number you do not trust
Because the sensor lags your blood and drifts, a single reading that clashes with how you feel is worth checking before you act. This matters most for anyone taking insulin or other glucose-lowering medication. If a low reading and your symptoms disagree, confirm with a fingerstick. If you feel a low, treat it whatever the sensor shows.
Watch for anxiety and over-restriction
In people without diabetes the readings can drive worry about ordinary meals and a steadily shrinking list of foods someone feels able to eat. Fruit, whole grains and legumes raise glucose and are foods a healthy body handles well. If wearing it is driving anxious eating or fear of ordinary foods, take the sensor off.
Skin reactions to the adhesive
The adhesive can cause itching, redness or a rash where the sensor sits, and reactions tend to build with repeated use. Rotating the site, letting the skin recover between sensors, and stopping if the skin breaks down are the usual measures. A spreading or blistering reaction is worth a clinician looking at it.
Start slow, be smart, read the research, and consult a professional if you have any concerns. This is here to inform your choice, not make it for you.
Go Deeper
- Type 2 diabetes: where monitoring sits among diet, movement and medication, and where its evidence is strongest.
- Post-meal walk: the change most worth testing on a monitor, and one that lowers the number the same evening.
- Insulin and glucose: the physiology underneath every reading, and why glucose climbs and falls after a meal.
- Whole foods: the dietary shift a curious self-experiment is most likely to reward.
Common Questions
Are glucose spikes after meals bad for me?
For a person with normal blood sugar, the glucose rise after a meal is expected and temporary. What harms the body is glucose that stays high around the clock, which is what defines diabetes. A single post-meal reading, seen on its own, says little about long-term risk in a healthy person.
Explore Related
Other pages this one connects to, by the evidence they share, the outcomes they touch, and the ground they cover.
All 12 sources on this page independently checked and cross-referenced.
Thomas Dehli, Founder & Editor, Sacred Lotus
Sacred Lotus has published Chinese medicine reference material since 2001. Integrative pages are held to the same standard as the herb and formula library: cite the source, grade the claim at its real strength, and say where the research has not looked. This page is educational and it is not medical advice. Last reviewed and updated August 9, 2026.
Evidence strength
How confidently the research supports a claim. Strength describes the evidence, not our endorsement.